4th Quarter - Report

FEDERAL STREET STRATEGIES, LLC for DENDREON PHARMACEUTICALS LLC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Prostate Cancer treatment and Medicare Part B payment reform. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.
DERRON PARKS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.